These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Bcl-2 phosphorylation and apoptosis activated by damaged microtubules require mTOR and are regulated by Akt. Asnaghi L; Calastretti A; Bevilacqua A; D'Agnano I; Gatti G; Canti G; Delia D; Capaccioli S; Nicolin A Oncogene; 2004 Jul; 23(34):5781-91. PubMed ID: 15208671 [TBL] [Abstract][Full Text] [Related]
5. Degradation of PKB/Akt protein by inhibition of the VEGF receptor/mTOR pathway in endothelial cells. Riesterer O; Zingg D; Hummerjohann J; Bodis S; Pruschy M Oncogene; 2004 Jun; 23(26):4624-35. PubMed ID: 15064712 [TBL] [Abstract][Full Text] [Related]
6. Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck. Amornphimoltham P; Patel V; Sodhi A; Nikitakis NG; Sauk JJ; Sausville EA; Molinolo AA; Gutkind JS Cancer Res; 2005 Nov; 65(21):9953-61. PubMed ID: 16267020 [TBL] [Abstract][Full Text] [Related]
7. [Drug resistance mediated by survival- and growth-promoting signaling pathways]. Fujita N Gan To Kagaku Ryoho; 2009 Apr; 36(4):567-71. PubMed ID: 19381028 [TBL] [Abstract][Full Text] [Related]
8. Phosphatidylinositol 3-kinase (PI-3K)/Akt but not PI-3K/p70 S6 kinase signaling mediates IGF-1-promoted lens epithelial cell survival. Chandrasekher G; Sailaja D Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3577-88. PubMed ID: 15452065 [TBL] [Abstract][Full Text] [Related]
9. Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53. Mungamuri SK; Yang X; Thor AD; Somasundaram K Cancer Res; 2006 May; 66(9):4715-24. PubMed ID: 16651424 [TBL] [Abstract][Full Text] [Related]
10. Akt activation protects pancreatic beta cells from AMPK-mediated death through stimulation of mTOR. Cai Y; Wang Q; Ling Z; Pipeleers D; McDermott P; Pende M; Heimberg H; Van de Casteele M Biochem Pharmacol; 2008 May; 75(10):1981-93. PubMed ID: 18377870 [TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway. Portis T; Longnecker R Oncogene; 2004 Nov; 23(53):8619-28. PubMed ID: 15361852 [TBL] [Abstract][Full Text] [Related]